Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer | NEJM Evidence
Cholangiocarcinoma - "Klatskin's" Tumors of the Bile Duct System - CancerConnect
Cholangiocarcinoma - Wikipedia
Comparison of the recurrence-free survival rates between hilar... | Download Scientific Diagram
Characterization of intrahepatic cholangiocarcinoma after curative resection: outcome, prognostic factor, and recurrence | BMC Gastroenterology | Full Text
SSAT - IMPROVED OVERALL SURVIVAL WITH INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM OF THE BILE DUCT: ANALYSIS OF A LARGE NATIONAL CANCER REGISTRY
Overall survival of patients with cholangiocarcinoma Kaplan Meier plot... | Download Scientific Diagram
Can bile duct cancer be cured? Survival rates, remission, and more
Overall survival stratified by stage group of distal bile duct... | Download Scientific Diagram
Survival outcomes and progonostic factors of extrahepatic cholangiocarcinoma patients following surgical resection: Adjuvant therapy is a favorable prognostic factor
Comparison of the overall-survival rates between hilar... | Download Scientific Diagram
Comparison of the overall-survival rates between hilar... | Download Scientific Diagram
Frontiers | The Evolving Role of Radiation Therapy in the Treatment of Biliary Tract Cancer
Survival according to overall tumor stage (f stage) of hilar or... | Download Scientific Diagram
The new insight of treatment in Cholangiocarcinoma
Distinct prognosis of biliary tract cancer according to tumor location, stage, and treatment: a population-based study | Scientific Reports
Overall survival rates for patients with distal bile duct cancer after... | Download Scientific Diagram
Cancers | Free Full-Text | Biliary Tract Cancers: Molecular Heterogeneity and New Treatment Options
Biliary tract cancers: NCDB role in rare malignancy | The Bulletin
Treatment outcomes and prognostic factors of intrahepatic cholangiocarcinoma
Current Oncology | Free Full-Text | A Population-Based Retrospective Study of Biliary Tract Cancers in Alberta, Canada
Dual-organ invasion is associated with a lower survival rate than single-organ invasion in distal bile duct cancer: A multicenter study | Scientific Reports
Cholangiocarcinoma 2020: the next horizon in mechanisms and management | Nature Reviews Gastroenterology & Hepatology
